OncoCyte Corp Insider Trading for July 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoCyte Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoCyte Corp for July 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2018 | OCX | OncoCyte Corp | ANNETT WILLIAM | President and CEO | Option Exercise | P | 3.00 | 3,500 | 10,500 | 3,500 | |
Jul 31 2018 | OCX | OncoCyte Corp | ANNETT WILLIAM | President and CEO | Buy | P | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | P | 3.00 | 3,495 | 10,485 | 3,495 | |
Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | Redmond Cavan M. | Director | Option Exercise | P | 3.00 | 52,447 | 157,341 | 52,447 | |
Jul 31 2018 | OCX | OncoCyte Corp | ANNETT WILLIAM | President and CEO | Option Exercise | P | 3.00 | 3,500 | 10,500 | 3,500 | |
Jul 31 2018 | OCX | OncoCyte Corp | Redmond Cavan M. | Director | Buy | P | 0.00 | 52,447 | 0 | 52,447 | 0 to 52.4 K |
Jul 31 2018 | OCX | OncoCyte Corp | ANNETT WILLIAM | President and CEO | Buy | P | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Option Exercise | P | 3.00 | 874 | 2,622 | 874 | |
Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Buy | P | 0.00 | 874 | 0 | 874 | 0 to 874 |
Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | P | 3.00 | 3,495 | 10,485 | 3,495 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
Jul 31 2018 | OCX | OncoCyte Corp | Arno Andrew | Director | Option Exercise | P | 3.00 | 52,447 | 157,341 | 52,447 | |
Jul 31 2018 | OCX | OncoCyte Corp | Redmond Cavan M. | Director | Option Exercise | P | 3.00 | 52,447 | 157,341 | 52,447 | |
Jul 31 2018 | OCX | OncoCyte Corp | Arno Andrew | Director | Buy | P | 0.00 | 52,447 | 0 | 52,447 | 0 to 52.4 K |
Jul 31 2018 | OCX | OncoCyte Corp | Redmond Cavan M. | Director | Buy | P | 0.00 | 52,447 | 0 | 52,447 | 0 to 52.4 K |
Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Option Exercise | P | 3.00 | 874 | 2,622 | 874 | |
Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Buy | P | 0.00 | 874 | 0 | 874 | 0 to 874 |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Jul 31 2018 | OCX | OncoCyte Corp | Arno Andrew | Director | Option Exercise | P | 3.00 | 52,447 | 157,341 | 52,447 | |
Jul 31 2018 | OCX | OncoCyte Corp | Arno Andrew | Director | Buy | P | 0.00 | 52,447 | 0 | 52,447 | 0 to 52.4 K |